C buffered with bioflavonoids
Natural health product licensed in Canada
- Other names
- C plus bioflavonoïdes, Progressive Laboratories
- Licence holder
- Bio Lonreco Inc.
- NPN or DIN-HM
- 80084422
- Status
- Inactive licence
- Licence date
- 12 April 2018
- Revision date
- 29 June 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 1,500 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine C Source : Ascorbate de calcium | 500 mg | 1,500,000 µg |
| Calcium Source : Ascorbate de calcium | 58 mg | 174,000 µg |
| Calcium Source : Thréonate de calcium | 58 mg | 174,000 µg |
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Citrus aurantium - fruit | 20 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone-3-rutinoside Source : Styphnolobium japonicum - Bourgeon floral | 15 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone Source : Dimorphandra mollis - graine | 15 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, farine de riz, L-Leucine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
Aide à la formation du tissu conjonctif. Favorise la cicatrisation des blessures. Source d'antioxydants qui réduit les effets secondaires des radicaux libres sur les fonctions physiologiques normales. Source d'antioxydants qui aident à réduire les radicaux libres et l'oxydation des lipides dans les tissus corporels. Source d'antioxydants qui aident à combattre/à protéger (les cellules) contre/à réduire (les effets oxydatifs des/les dommages oxydatifs causés par/les dommages cellulaires causés par) les radicaux libres. Aide à la formation du collagène pour maintenir la santé des os, des cartilages, des dents et/ou des gencives. Aide au maintien des fonctions immunitaires. Aide à maintenir les capacités du corps à métaboliser les nutriments.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Si vous êtes enceinte ou allaitez, consultez un praticien de soins de santé avant d'en faire l'usage.
Source
Official Health Canada record, licence 80084422
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging